Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: J Cardiovasc Pharmacol. 2012 Jun;59(6):487–499. doi: 10.1097/FJC.0b013e31824ba6b5

Fig. 1.

Fig. 1

CASMC and HCAEC cell growth after treatment with NSAIDs. Cells were treated with CXB (10μmol/L and 40μmol/L), NS (10μmol/L and 100μmol/L) and IBU (0.1mmol/L and 1.5mmol/L) for 24h. Data points represent percent cell growth following NSAID treatment normalized to vehicle controls (mean ± SEM, n=3). The difference between low and high IBU was significant. †p<0.05